Top Markets
Coin of the day
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO
Classement en actions #91
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical... Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Prix de l'action
$475.89
Capitalisation boursière
$176.79B
Changement (1 jour)
-4.00%
Changement (1 an)
-7.17%
Pays
US
Échange Thermo Fisher Scientific Inc. (TMO)

Catégorie

Ratio P/E pour Thermo Fisher Scientific Inc. (TMO)
Ratio P/E au March 2026 TTM : 29.18
Selon les derniers rapports financiers et le cours de l'action de Thermo Fisher Scientific Inc., le ratio P/E actuel (TTM) est de 29.18. À la fin de l’année 2024, le P/E de l’entreprise était de 31.37.
Historique du ratio P/E pour Thermo Fisher Scientific Inc. de 2000 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) 29.18 -9.77%
2025 32.34 3.09%
2024 31.37 -8.21%
2023 34.18 10.03%
2022 31.06 -8.73%
2021 34.03 17.62%
2020 28.93 -17.71%
2019 35.16 14.82%
2018 30.62 -9.16%
2017 33.71 22.34%
2016 27.55 -3.76%
2015 28.63 8.71%
2014 26.34 -16.42%
2013 31.51 59.95%
2012 19.70 52.98%
2011 12.88 -40.27%
2010 21.56 -6.79%
2009 23.13 61.40%
2008 14.33 -55.14%
2007 31.94 -39.24%
2006 52.57 141.04%
2005 21.81 60.24%
2004 13.61 -33.61%
2003 20.50 88.61%
2002 10.87 -100.20%
2001 -5.50K 4,633.22%
2000 -116.27 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
41.22 41.28%
US
49.65 70.15%
US
18.53 -36.50%
CN
26.63 -8.74%
US
22.35 -23.40%
US
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.